To further evaluate the relationship of MINA53 and CMG genes in vivo, we analyzed their expression level in two TCGA clinical databases: Glioblastoma (Cell 2013)56 and Brain low grade glioma (http://www.cbioportal.org/index.do). The gene discussed is RIOX2; the disease is glioma.